Stockscreener 앱 받기
343.91
1.28%
4.34
시간 외 거래:
343.91
전일 마감가:
$339.57
열려 있는:
$342.88
하루 거래량:
386.94K
Relative Volume:
0.73
시가총액:
$24.95B
수익:
$2.88B
순이익/손실:
$499.60M
주가수익비율:
51.03
EPS:
6.74
순현금흐름:
$321.60M
1주 성능:
-0.02%
1개월 성능:
+4.59%
6개월 성능:
+14.82%
1년 성능:
-8.56%
1일 변동 폭
$341.88
$347.85
1주일 범위
$335.62
$348.90
52주 변동 폭
$265.00
$413.70
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
WST을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
343.91 | 24.95B | 2.88B | 499.60M | 321.60M | 6.74 |
|
ISRG
Intuitive Surgical Inc
|
580.18 | 206.65B | 8.35B | 2.32B | 586.00M | 6.41 |
|
BDX
Becton Dickinson Co
|
248.49 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
92.32 | 45.20B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
257.65 | 37.85B | 4.81B | 1.11B | 1.35B | 7.55 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services, Inc. to Issue Quarterly Dividend of $0.21 (NYSE:WST) - MarketBeat
West Pharmaceutical's Critical Q4 Earnings: Key Focus on Healthcare Supply Chain Performance - StockTitan
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
West Introduces Daikyo PLASCAP RUV closures in new nested format at Pharmapack - European Pharmaceutical Manufacturer
Fulton Breakefield Broenniman LLC Takes Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical sets first-quarter dividend at $0.21/share By Investing.com - Investing.com Canada
West Pharmaceutical sets first-quarter dividend at $0.21/share - MSN
West Pharmaceutical Services Maintains Quarterly Dividend at $0.21 Per Share; Payable Feb. 11 to Shareholders of Record on Feb. 7 - Marketscreener.com
West Announces First-Quarter Dividend - PR Newswire
West Pharmaceutical Services (NYSE:WST) shareholders have earned a 17% CAGR over the last five years - Simply Wall St
Vial Closure From: West Pharmaceutical Services, Inc - Healthcare Packaging
Janney Montgomery Scott LLC Makes New $14.76 Million Investment in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Unveils New Nested Format for Daikyo PLASCAP RUV Closures - MSN
What You Need to Know Ahead of West Pharmaceutical Services’ Earnings Release - MSN
Beacon Investment Advisory Services Inc. Sells 2,138 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Riverbridge Partners LLC - MarketBeat
West launches Daikyo PLASCAP RUV closures in new nested format - Packaging Gateway
West Pharmaceutical Services, Inc. Introduces Daikyo PLASCAP RUV Closures in New Nested Format At Pharmapack - Marketscreener.com
Mitsubishi UFJ Asset Management UK Ltd. Decreases Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack – Company Announcement - Financial Times
What You Need To Know Ahead Of West Pharmaceutical Services’ Earnings Release - Barchart
AMI Asset Management Corp Sells 1,486 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Reasons to Hold West Pharmaceutical Stock in Your Portfolio Now - MSN
Artemis Investment Management LLP Takes $20.91 Million Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Seilern Investment Management Ltd Purchases Shares of 443,825 West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Annex Advisory Services LLC Has $15.94 Million Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Avanza Fonder AB Purchases New Holdings in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Park Avenue Securities LLC Has $2.86 Million Stock Position in West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Assenagon Asset Management S.A. Acquires 60,545 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
(WST)Analyzing West Pharmaceutical Servs's Short Interest - Benzinga
Czech National Bank Buys 926 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
Rockland Trust Co. Purchases 3,102 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - MarketBeat
YieldBoost West Pharmaceutical Services To 6.3% Using Options - Nasdaq
West Pharmaceutical Services, Inc. (NYSE:WST) Shares Sold by Bright Rock Capital Management LLC - MarketBeat
West Pharmaceutical Services to Present at CJS Annual Virtual Investor Conference - MSN
Deerfield Group Expands Focus on West Coast Biotech and Pharmaceutical Markets - MyChesCo
West Pharmaceutical Services started at buy by Citi - MSN
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
Citigroup Initiates Coverage of West Pharmaceutical Services (WST) with Buy Recommendation - MSN
West Pharmaceutical Services (NYSE:WST) Now Covered by Citigroup - MarketBeat
West Pharmaceuticals: Cannot Wrap My Head Around Valuations (Rating Downgrade) (NYSE:WST) - Seeking Alpha
U.S. Pharmaceutical Packaging Services Market Report, 2030 - Grand View Research
West Pharmaceutical Services Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
WSTWest Pharmaceutical Services, Inc. Latest Stock News & Market Updates - StockTitan
West Pharmaceutical Services, Inc. (NYSE:WST) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
West Pharmaceutical Services to Present at the CJS 25th Annual "New Ideas for the New Year" Investor Conference - The Malaysian Reserve
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.10%
자본화:
|
볼륨(24시간):